Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) have been investigated as promising candidates for use in new cell-based therapeutic strategies such as mesenchyme-derived tissue repair. MSCs are easily isolated from adult tissues and are not ethically restricted. MSC-related literature, however, is conflicting in relation to MSC differentiation potential and molecular markers. Here we compared MSCs isolated from bone marrow (BM), umbilical cord blood (UCB), and adipose tissue (AT). The isolation efficiency for both BM and AT was 100%, but that from UCB was only 30%. MSCs from these tissues are morphologically and immunophenotypically similar although their differentiation diverges. Differentiation to osteoblasts and chondroblasts was similar among MSCs from all sources, as analyzed by cytochemistry. Adipogenic differentiation showed that UCB-derived MSCs produced few and small lipid vacuoles in contrast to those of BM-derived MSCs and AT-derived stem cells (ADSCs) (arbitrary differentiation values of 245.57 ± 943 and 243.89 ± 145.52 μm 2 per nucleus, respectively). The mean area occupied by individual lipid droplets was 7.37 μm 2 for BM-derived MSCs and 2.36 μm 2 for ADSCs, a finding indicating more mature adipocytes in BM-derived MSCs than in treated cultures of ADSCs. We analyzed FAPB4, ALP, and type II collagen gene expression by quantitative polymerase chain reaction to confirm adipogenic, osteogenic, and chondrogenic differentiation, respectively. Results showed that all three sources presented a similar capacity for chondrogenic and osteogenic differentiation and they differed in their adipogenic potential. Therefore, it may be crucial to predetermine the most appropriate MSC source for future clinical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced or entire lack of adipogenic differentiation potential has been repeatedly reported for perinatal MSCs [27, 28].”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052 · cited 5×
“dependent on specific environmental effectors: usually a combination of growth factors and cytokines supplied in vitro (1, 16).”
BackgroundInfluentialDominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The direct comparison reported here showed that BM-derived and UCB-derived MSCs and ADSCs share classic MSC marker proteins (52).”
BackgroundIsolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664 · cited 1×
“Adipose tissue–derived stem cells (ADSCs) are available in quantities of hundreds of million cells per individual (9), have an extensive self-renewal capacity (36), are easily isolated by differential sedimentation, and can be cultured for several months in vitro with low levels of senescence (37).”
BackgroundKern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“(17); however, similar populations have been reported in other tissues, such as peripheral blood (18), cord blood (19), trabecular bone (20), adipose tissue (1), synovium (21), skin (22), muscle, and brain (23).”
BackgroundThe Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel Filtration
Mogensen, C. E. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076979 · Cited by 2,654
Mesenchymal stem cells reside in virtually all post-natal organs and tissues
Meirelles, L. D. S., Chagastelles, P. C., & Nardi, N. B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02932 · Cited by 2,485 · cited 8×
“Without disturbing the pellet, cells were cultured for 21 days in three different chondrogenic media: medium 7 consisted of DMEM-HG supplemented with 15% FCS and 0.01 l M dexamethasone, 397 l g/ml ascorbic acid-2-phosphate (Sigma-Aldrich), 1 m M sodium pyruvate (Gibco Invitrogen), 10 ng/ml TGF-b 1 (Sigma-Aldrich), and…”
MethodInfluentialIn VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Research works printed but not linked: 2
- 10.1002/1529-0131(200101)44:1<85::aid-anr12>3.0.co;2-6 · doi:10.1002/1529-0131(200101)44:1<85::aid-anr12>3.0.co;2-6
- 10.1073/pnas.97.7.3213 · doi:10.1073/pnas.97.7.3213 · Paper page
Cited by
Isolation, cultivation, and characterization of human mesenchymal stem cells
Mushahary, D., Spittler, A., Kasper, C., Weber, V., & Charwat, V. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23242 · Cited by 599
The Potential of Adipose Stem Cells in Regenerative Medicine
Lindroos, B., Suuronen, R., & Miettinen, S. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9193-7 · Cited by 441
“CD31 +/± [75, 85, 147, 172, 219, 221, 222] ± [98, 147, 172, 219] ± [98, 172]”
Stem cells in dentistry – Part I: Stem cell sources
Egusa, H., Sonoyama, W., Nishimura, M., Atsuta, I., & Akiyama, K. (2012) · Journal of Prosthodontic Research · doi:10.1016/j.jpor.2012.06.001 · Cited by 374
“Although the intrinsic characteristics of ASCs appear to be different from those of BMSCs [26,130–132], ASCs exhibit robust osteogenesis and are thus expected to be an alternative source of MSCs for bone regeneration in dentistry.”
BackgroundKidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030563 · Cited by 371
The Regulation of Differentiation in Mesenchymal Stem Cells
Augello, A., & De Bari, C. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.173 · Cited by 370
“Furthermore, data showed that MSCs from different tissues present phenotypic heterogeneity and different growth abilities (Baksh et al. , 2007; Rebelatto et al. , 2008), reflecting a tissue specificity that could be correlated to marked biological and functional differences (De Bari et al. , 2008).”
Gentile, P., & Garcovich, S. (2019) · Cells · doi:10.3390/cells8050466 · Cited by 333
“These outcomes were confirmed by other examinations that emphasized the evaluation of various grownup, undifferentiated cell sources [48,50].”
Perivascular Ancestors of Adult Multipotent Stem Cells
Corselli, M., Chen, C.-W., Crisan, M., Lazzari, L., & Péault, B. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.191643 · Cited by 309
Diekman, B. O., Rowland, C. R., Lennon, D. P., Caplan, A. I., & Guilak, F. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0398 · Cited by 267
MSCs: Biological characteristics, clinical applications and their outstanding concerns
Si, Y.-L., Zhao, Y.-L., Hao, H.-J., Fu, X.-B., & Han, W.-D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.005 · Cited by 259
“…/ Ageing Rese iew of the potential promotion roles of MSCs for tumor cell surival and metastasis by their mutual interactions (Karnoub et al., 007; Roorda et al., 2009), we should be extremely cautious before nfusing MSCs into the patients with tumors such as neuroblasoma and bone neoplasms, and…”
BackgroundHuman dental pulp stem cells: Applications in future regenerative medicine
Potdar, P. D. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i5.839 · Cited by 238
Kang, S. K., Shin, I. S., Ko, M. S., Jo, J. Y., & Ra, J. C. (2012) · Stem Cells International · doi:10.1155/2012/342968 · Cited by 232
“MSCs are found in various tissues and organs, including fat, periosteum, synovial membrane, synovial fluid, muscle, dermis, deciduous teeth, pericytes, trabecular bone, infrapatellar fat pad, articular cartilage, umbilical cord and cord blood [37, 38], and the placenta [39].”
BackgroundStem cells in bone tissue engineering
Seong, J. M., Kim, B.-C., Park, J.-H., Kwon, I. K., Mantalaris, A., & Hwang, Y.-S. (2010) · Biomedical Materials · doi:10.1088/1748-6041/5/6/062001 · Cited by 225
“UCB-MSCs have been reported to be positive for various markers, such as CD9, CD13, CD29, CD44, CD54, CD73, CD90 and CD105 (Markov et al 2007, Gang et al 2004, Rosada et al 2003, Rebelatto et al 2008) which is an extremely similar expression pattern as that observed with BM-MSCs.”
BackgroundResultChen, Y. S., Pelekanos, R. A., Ellis, R. L., Horne, R., Wolvetang, E. J., & Fisk, N. M. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0022 · Cited by 216
Secunda, R., Vennila, R., Mohanashankar, A. M., Rajasundari, M., Jeswanth, S., & Surendran, R. (2015) · Cytotechnology · doi:10.1007/s10616-014-9718-z · Cited by 205
“This is concordant with the report of Rebelatto et al. (2008).”
ResultSutendra, G., Dromparis, P., Kinnaird, A., Stenson, T. H., Haromy, A., Parker, J. M. R., McMurtry, M. S., & Michelakis, E. D. (2013) · Oncogene · doi:10.1038/onc.2012.198 · Cited by 184
Life-Sparing Effect of Human Cord Blood-Mesenchymal Stem Cells in Experimental Acute Kidney Injury
Morigi, M., Rota, C., Montemurro, T., Montelatici, E., Lo Cicero, V., Imberti, B., Abbate, M., Zoja, C., Cassis, P., Longaretti, L., et al. (2010) · Stem Cells · doi:10.1002/stem.293 · Cited by 184
Ra, J. C., Kang, S. K., Shin, I. S., Park, H. G., Joo, S. A., Kim, J. G., Kang, B.-C., Lee, Y. S., Nakama, K., Piao, M., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-181 · Cited by 179
“[36,37], and placenta [38].”
The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy
Li, J., Wu, Z., Zhao, L., Liu, Y., Su, Y., Gong, X., Liu, F., & Zhang, L. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03587-y · Cited by 150
“The experimental results showed that AD-MSCs have a stronger adipogenic differentiation capacity and produce more cellular matrix components, which may be due to the high expression of fatty acid-binding protein FABP4 in AD-MSCs compared to BM-MSCs [85].”
ResultKimbrel, E. A., Kouris, N. A., Yavanian, G. J., Chu, J., Qin, Y., Chan, A., Singh, R. P., McCurdy, D., Gordon, L., Levinson, R. D., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0554 · Cited by 174
“While research indicates that different sources of MSCs may have different properties [86,87], the data collectively presented here illustrate that hESC-MSCs are a viable alternative to adult-derived MSCs with the added benefit that they can circumvent many problems associated with adult-tissue derived MSCs.”
Mesenchymal stem cells and bone regeneration: Current status
Jones, E., & Yang, X. (2011) · Injury · doi:10.1016/j.injury.2011.03.030 · Cited by 173
Martinello, T., Bronzini, I., Maccatrozzo, L., Mollo, A., Sampaolesi, M., Mascarello, F., Decaminada, M., & Patruno, M. (2010) · Research in Veterinary Science · doi:10.1016/j.rvsc.2010.07.024 · Cited by 170
“An adult mesenchymal progenitor cell population was identified in human adipose tissue and lipoaspirate (Zuk et al., 2002; Lee et al., 2004; Kern et al., 2006; Rebelatto et al., 2008).”
BackgroundResultInfluentialChondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors
Boeuf, S., & Richter, W. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt31 · Cited by 163
“While absence of CD34 is generally considered as a criterion for the defi nition of MSCs [20], some investigators have reported low expression in AT MSCs [46, 51 ,53] and one group described selected cell populations with multidiff erentiation potential from AT using CD34 [54].”
BackgroundRobert, A. W., Marcon, B. H., Dallagiovanna, B., & Shigunov, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00561 · Cited by 161
Lotfy, A., Salama, M., Zahran, F., Jones, E., Badawy, A., & Sobh, M. (2014) · International Journal of Stem Cells · doi:10.15283/ijsc.2014.7.2.135 · Cited by 159
Mennan, C., Wright, K., Bhattacharjee, A., Balain, B., Richardson, J., & Roberts, S. (2013) · BioMed Research International · doi:10.1155/2013/916136 · Cited by 158
“Other studies report smaller lipid droplets from UCMSC derived from UC blood [19].”
BackgroundSharma, V., Srinivasan, A., Nikolajeff, F. K., & Kumar, S. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.049 · Cited by 158
Gaebel, R., Furlani, D., Sorg, H., Polchow, B., Frank, J., Bieback, K., Wang, W., Klopsch, C., Ong, L.-L., Li, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015652 · Cited by 141
“hMSC derived from different human sources are well characterized and share a consistent and reproducible gene expression profile [33], however they may behave differently with respect to morphology, expansion rate and differentiation potential under in vitro conditions [34,40,41].”
BackgroundPatrikoski, M., Juntunen, M., Boucher, S., Campbell, A., Vemuri, M. C., Mannerström, B., & Miettinen, S. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt175 · Cited by 151
“However, similar results for CD34 expression have been reported by others [36,37], and the variable interpretations could be explained by differences cell-culturing and -passaging protocols.”
ResultGenetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy
Hodgkinson, C. P., Gomez, J. A., Mirotsou, M., & Dzau, V. J. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.165 · Cited by 150
Izadi, M., Nejad, A. S. H., Moazenchi, M., Masoumi, S., Rabbani, A., Kompani, F., Asl, A. A. H., Kakroodi, F. A., Jaroughi, N., Meybodi, M. A. M., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02941-w · Cited by 148
“Also, it has been shown that UCB-derived MSCs barely showed adipogenic differentiation potential compared to BM-MSCs, which are fully capable of differentiating to osteoblasts, chondrocytes, and adipocytes [54].”
BackgroundA Comprehensive Review on Mesenchymal Stem Cell Growth and Senescence
Książek, K. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0830 · Cited by 131
“40,41 In this context it should also be emphasized that cells from umbilical blood, apart from their higher expandability in vitro , have been found to support the long-term culture-initiating frequency of hematopoietic progenitors more efficiently than cultures established from adipose tissue.”
Signaling network regulating osteogenesis in mesenchymal stem cells
Thomas, S., & Jaganathan, B. G. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00635-1 · Cited by 146
Human mesenchymal stem cells and their use in cell‐based therapies
Motaln, H., Schichor, C., & Lah, T. T. (2010) · Cancer · doi:10.1002/cncr.25056 · Cited by 129
Adult stem cell-based tissue engineered blood vessels: A review
Krawiec, J. T., & Vorp, D. A. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.014 · Cited by 144
“who also showed that umbilical cord MSCs could not differentiate toward an adipogenic lineage [44].”
BackgroundUrrutia, D. N., Caviedes, P. A., MARDONES, R. M., Minguell, J. J., Vega-Letter, A. M., & Jofré, C. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213032 · Cited by 143
Gentile, P., Calabrese, C., Angelis, B. D., Pizzicannella, J., Kothari, A. S., & Garcovich, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215471 · Cited by 143
Kim, S. M., Oh, J. H., Park, S. A., Ryu, C. H., Lim, J. Y., Kim, D.-S., Chang, J. W., Oh, W., & Jeun, S.-S. (2010) · Stem Cells · doi:10.1002/stem.543 · Cited by 136
Comparison of human mesenchymal stem cells derived from adipose and cord tissue
Choudhery, M. S., Badowski, M., Muise, A., & Harris, D. T. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.11.010 · Cited by 142
“Our data are in accordance with other studies showing more mature adipocytes obtained from AT-MSCs (15).”
BackgroundResultInfluentialLiu, L.-T., Huang, B. S., Li, C., Zhuang, Y., Wang, J., & Zhou, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026285 · Cited by 141
“differentiation by morphology, the differentiation value (DV) method was adopted as previously described [25].”
BackgroundMethodMesenchymal Stem Cells: Characteristics, Sources, and Mechanisms of Action
Stewart, M. C., & Stewart, A. A. (2011) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2011.06.004 · Cited by 141
Cord blood research, banking, and transplantation: achievements, challenges, and perspectives
Mayani, H., Wagner, J. E., & Broxmeyer, H. E. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0546-9 · Cited by 138
Journey into Bone Models: A Review
Scheinpflug, J., Pfeiffenberger, M., Damerau, A., Schwarz, F., Textor, M., Lang, A., & Schulze, F. (2018) · Genes · doi:10.3390/genes9050247 · Cited by 137
“Thus, Gurumurthy et al. were able to show superior osteogenic differentiation of human AT-MSCs in a 3D spheroid culture when compared to monolayer cultivation [80].”
BackgroundResultInfluentialStem Cell Therapy for Osteoporosis
Antebi, B., Pelled, G., & Gazit, D. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0184-x · Cited by 132
“Gazit Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA Curr Osteoporos Rep (2014) 12:41–47”
Zhao, Q., Zhang, L., Wei, Y., Yu, H., Zou, L., Huo, J., Yang, H., Song, B., Wei, T., Wu, D., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1478-4 · Cited by 128
Sivaraman, D. M., Roshin, G. E., Divya, T. S., Rasheed, V. A., Santhoshkumar, T. R., Elizabeth, K. E., James, J., & Pillai, R. M. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt148 · Cited by 127
“Recent reports have also shown, however, that the percentage of robust rapidly expanding MSCs obtained from UCB is very low [32,33].”
Carvalho, M. M., Teixeira, F. G., Reis, R. L., Sousa, N., & Salgado, A. J. (2011) · Current Stem Cell Research & Therapy · doi:10.2174/157488811796575332 · Cited by 120
“Inconsistencies in culture protocols can help explain such variation, but interestingly even when cultured under the same conditions, some MSC populations were shown to have limited capacity to derivate into certain cell types [28-31].”
BackgroundBobis‐Wozowicz, S., Miękus, K., Wybieralska, E., Jarocha, D. J., Zawisz, A., Madeja, Z., & Majka, M. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.03.004 · Cited by 119
Najar, M., Raicevic, G., Boufker, H. I., Fayyad‐Kazan, H., Bruyn, C. D., Meuleman, N., Bron, D., Toungouz, M., & Lagneaux, L. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0159 · Cited by 117
“25 These functional differences could be related to distinct gene profiles.”
Myoblasts Differentiated From Adipose-derived Stem Cells to Treat Stress Urinary Incontinence
Fu, Q., Song, X.-F., Guo-long, L., Deng, C.-L., & Cui, L. (2009) · Urology · doi:10.1016/j.urology.2009.10.003 · Cited by 117
Manufacturing artificial bone allografts: a perspective.
Steijvers, E., Ghei, A., & Xia, Z. (2022) · PubMed Central · doi:10.12336/biomatertransl.2022.01.007 · Cited by 116
“78, 80 A solution relying on only umbilical cord blood MSCs may therefore be less suitable, though there may be merit in using them in conjunction with umbilical cord matrix MSCs to avoid waste.”
De Bruyn, C., Najar, M., Raicevic, G., Meuleman, N., Pieters, K., Stamatopoulos, B., Delforge, A., Bron, D., & Lagneaux, L. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0260 · Cited by 98
“These results are consistent with previous data described on WJs [54] and on cord blood MSCs [55].”
Elfayomy, A. K., Almasry, S. M., Tarhouny, S. A. E., & Eldomiaty, M. A. (2016) · Tissue and Cell · doi:10.1016/j.tice.2016.05.001 · Cited by 108
Martinello, T., Bronzini, I., Maccatrozzo, L., Iacopetti, I., Sampaolesi, M., Mascarello, F., & Patruno, M. (2009) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2009.0512 · Cited by 103
“As suggested by several studies, 10,12,37 MSC possess the potential to differentiate into multiple mesodermal lineages after exposure to specific culture conditions.”
Koch, T. G., Heerkens, T. M.-J., Besonov, K., Thomsen, P. D., Betts, D. H., & Berg, L. C. (2009) · Veterinary and Comparative Orthopaedics and Traumatology · doi:10.3415/vcot-08-10-0107 · Cited by 103
A critical review of fibrous polyurethane-based vascular tissue engineering scaffolds
Fathi‐karkan, S., Banimohamad‐Shotorbani, B., Saghati, S., Rahbarghazi, R., & Davaran, S. (2022) · Journal of Biological Engineering · doi:10.1186/s13036-022-00286-9 · Cited by 104
“Although the lowest harvest frequency was reported for umbilical cord MSCs, these cells exhibited showed the highest proliferation potential [92, 93].”
BackgroundTan, S., Ahmad, T. S., Selvaratnam, L., & Kamarul, T. (2013) · Journal of Anatomy · doi:10.1111/joa.12032 · Cited by 103
“In isolated adipose tissue-derived stem cells, CD117 and HLA-DR expres- sion have also been reported (Varma et al. 2007; Rebelatto et al. 2008).”
BackgroundXie, H., Cao, T., Viana‐Gomes, J., Neto, A. H. C., & Rosa, V. (2015) · Carbon · doi:10.1016/j.carbon.2015.05.071 · Cited by 100
“[22] Rebelatto CK, Aguiar AM, Moretao MP, Senegaglia AC, Hansen P, Barchiki F, et al.”
BackgroundBurrow, K. L., Hoyland, J. A., & Richardson, S. M. (2017) · Stem Cells International · doi:10.1155/2017/2541275 · Cited by 87
“The original studies into ASCs also demonstrated similar multilineage differentiation potential to MSCs, although subsequent studies suggest that ASCs may have enhanced, equivalent, or diminished osteogenic [17–20], chondrogenic [18, 21–25], and adipogenic [19, 23, 24, 26, 27] potential compared to MSCs [28].”
ResultIsolation, Characterization, and Differentiation of Stem Cells for Cartilage Regeneration
Beane, O. S., & Darling, E. M. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0639-8 · Cited by 95
Bone Organoids: Recent Advances and Future Challenges
Zhao, D., Saiding, Q., Li, Y., Tang, Y., & Cui, W. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302088 · Cited by 94
Musculoskeletal tissue engineering: Regional gene therapy for bone repair
Collon, K. W., Gallo, M. C., & Lieberman, J. R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120901 · Cited by 90
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
Cheung, T. S., Bertolino, G. M., Giacomini, C., Bornhäuser, M., Dazzi, F., & Galleu, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01338 · Cited by 89
“Third, they have higher proliferative capacity and longer life-span in vitro with higher cells yielded per expansion (94, 95).”
BackgroundAdipose tissue-derived stem cells in clinical applications
Pikuła, M., Marek-Trzonkowska, N. M., Wardowska, A., Renkielska, A., & Trzonkowski, P. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.823153 · Cited by 89
“In addition, there are animal and human studies which show that MSCs derived from adipose tissue, bone marrow, umbilical cord blood (UB-MSCs) and cartilage (C-MSCs) vary in differentiation preferences [37,43].”
BackgroundInfluentialKim, D.-S., Kim, J. H., Kwon Lee, J., Choi, S. J., Kim, J.-S., Jeun, S.-S., Oh, W., Yang, Y. S., & Chang, J. W. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0050 · Cited by 85
“BM-MSCs exhibited a high in vitro capacity to differentiate into adipocytes, osteoblasts, and chondrocytes, whereas UCB-MSCs presented a more restricted, or at least delayed, adipocyte differentiation capacity [7].”
de Oliveira, H. G., Cruz, F. F., Antunes, M. A., Neto, A. V. M., de Oliveira, G. A., Svartman, F. M., Borgonovo, T., Rebelatto, C. L. K., Weiss, D. J., Brofman, P. R. S., et al. (2016) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0315 · Cited by 88
Self-citationMore insight into mesenchymal stem cells and their effects inside the body
Zou, Z., Zhang, Y., Hao, L., Wang, F., Liu, D., Su, Y., & Sun, H. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903456011 · Cited by 88
“MSCs from bone marrow, UCB and adipose tissue have been demonstrated to be morphologically and immunophenotypically similar, and their differentiation to osteoblasts and chondroblasts is similar, but adipogenic differentiation is of low efficiency in UCB-derived MSCs [21].”
BackgroundSachs, P. C., Francis, M. P., Zhao, M., Brumelle, J., Rao, R. R., Elmore, L. W., & Holt, S. E. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1423-7 · Cited by 87
“…down multiple mesenchymal lineages as reported previously (Izadpanah et al. 2006; Zuk et al. 2001; Astori et al. 2007; Katz et al. 2005; Kern et al. 2006; Leong et al. 2005; Lin et al. 2008a, b; Noël et al. 2008; Rebelatto et al. 2008; Wagner et al. 2005; Yoshimura et al. 2006; Zhu et al. 2008).”
BackgroundMethodResultInfluentialChung, D., Hayashi, K., Toupadakis, C. A., Wong, A., & Yellowley, C. E. (2010) · Research in Veterinary Science · doi:10.1016/j.rvsc.2010.10.012 · Cited by 86
Witkowska-Zimny, M., Walenko, K., Wróbel, E., Mrówka, P., Mikulska, A., & Przybylski, J. (2013) · Cell Biology International · doi:10.1002/cbin.10078 · Cited by 85
“BM-MSCs were isolated according to methods described by Rebelatto et al. (2008).”
MethodKim, Y., & Broxmeyer, H. E. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.07.009 · Cited by 84
“UCBMSC can be cultured for longer with a higher proliferation capacity compared with MSC derived from BM and AT [130,156-158,185-186].”
BackgroundResultAraújo, A. B., Salton, G. D., Furlan, J. M., Schneider, N., Angeli, M. H., Laureano, Á. M., Silla, L., Passos, E. P., & Paz, A. H. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.03.001 · Cited by 83
Wei, Y., Zhang, L., Chi, Y., Ren, X., Gao, Y., Song, B., Li, C., Han, Z., Zhang, L., & Han, Z. (2020) · Cell Proliferation · doi:10.1111/cpr.12862 · Cited by 81
Prabakar, K. R., Domínguez‐Bendala, J., Molano, R. D., Pileggi, A., Villate, S., Ricordi, C., & Inverardi, L. (2012) · Cell Transplantation · doi:10.3727/096368911x612530 · Cited by 82
Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches
Paspaliaris, V., & Kolios, G. C. (2019) · Stem Cells International · doi:10.1155/2019/1730978 · Cited by 82
Zhang, L., Chi, Y., Wei, Y., Zhang, W., 王福旭, Zhang, L., Zou, L., Song, B., Zhao, X., & Han, Z. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02444-0 · Cited by 80
“On the one hand, an appreciable quantity of investigators concentrates on illuminating the similarities and distinctions of MSCs with different origins such as the bone marrow (BM-MSCs), umbilical cord (UC-MSCs), adipose (AD-MSCs), dental pulpal (DPSC), and even human pluripotent stem cells (hPSCMSCs), which would be…”
BackgroundHuman umbilical cord mesenchymal stem cell transplantation restores damaged ovaries
Zhu, S., Hu, H., Xu, H., Fu, X., Peng, D., Su, W., & He, Y. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12571 · Cited by 80
“Furthermore, it has been shown that bone marrow-derived MSCs (BMSCs) can cause secondary damage in patients following transplantation [15].”
BackgroundInfluentialMesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury
Russo, V., Young, S., Hamilton, A., Amsden, B. G., & Flynn, L. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.075 · Cited by 78
“n culturing [35,36] Expression of CD34 in freshly isolated cells [29,30] CD49dþ, CD54þ, CD106 , CD49f and”
Adipose tissue as a stem cell source for musculoskeletal regeneration
Gimble, J. M., Grayson, W. L., Guilak, F., Lopez, M. J., & Vunjak‐Novakovic, G. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s133 · Cited by 78
“While some investigators have concluded that they function equally well with respect to chondrogenic and osteogenic differentiation, others have concluded that BMSCs show some superior qualities with respect to differentiation potential (27-33).”
Angulski, A. B. B., Capriglione, L. G. A., Batista, M., Marcon, B. H., Senegaglia, A. C., Stimamiglio, M. A., & Correa, A. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9715-z · Cited by 76
Self-citationAdipose-Derived Stem Cell Delivery into Collagen Gels Using Chitosan Microspheres
Natesan, S., Baer, D. G., Walters, J., Babu, M., & Christy, R. J. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0404 · Cited by 75
Cord blood transplantation and stem cell regenerative potential
Liao, Y., Geyer, M. B., Yang, A., & Cairo, M. S. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.01.002 · Cited by 74
“100% of UCB units, respectively) [99].”
Engineered mesenchymal stem/stromal cells against cancer
Shi, Y., Zhang, J., Li, Y., Feng, C., Shao, C., Shi, Y., & Fang, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07443-0 · Cited by 74
“As one of the most widespread cell types in the human body, MSCs exhibit an exceptional capacity to differentiate into multiple mesenchymal cell lineages, such as adipocytes, osteocytes, and chondrocytes [7, 8].”
Pietilä, M., Palomäki, S., Lehtonen, S. T., Ritamo, I., Valmu, L., Nystedt, J. M., Laitinen, S., Leskelä, H.-V., Sormunen, R. T., Pesälä, J., et al. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0023 · Cited by 73
“Several comparative studies on differentiation potency, proliferation rate, immunophenotype, and gene expression of hMSCs from different sources have been previously conducted [16–21].”
Han, I., Kwon, B. S., Park, H., & Kim, K. S. (2017) · International Neurourology Journal · doi:10.5213/inj.1734856.428 · Cited by 73
“ADSCs and BMSCs differentiated well into adipocytes, but UCSCs differentiated poorly [16].”
BackgroundExploring the mesenchymal stem cell niche using high throughput screening
Ghaemi, S. R., Harding, F. J., Delalat, B., Gronthos, S., & Voelcker, N. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.022 · Cited by 71
“MSC colonies arising from tissue) [29,38]”
Adipose stem cells for bone tissue repair
Ciuffi, S., Zonefrati, R., & Brandi, M. L. (2017) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2017.14.1.217 · Cited by 72
Lam, A. T., Li, J., Toh, J. P. W., Sim, E., Chen, A. K.-L., Chan, J. K. Y., Choolani, M. A., Reuveny, S., Birch, W. R., & Oh, S. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.11.009 · Cited by 71
External factors influencing mesenchymal stem cell fate in vitro
Sisakhtnezhad, S., Alimoradi, E., & Akrami, H. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.11.003 · Cited by 70
Yan, J., Tie, G., Xu, T., Cecchini, K. R., & Messina, L. M. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9433-8 · Cited by 69
“Despite the similarity of the cell surface marker expression, MSCs derived from different sources nonetheless do exhibit heterogeneity in colony formation rates and differentiation potential [26–28].”
BackgroundHuman embryonic stem cell-derived CD34+ cells function as MSC progenitor cells
Kopher, R. A., Penchev, V. R., Islam, M. S., Hill, K. L., Khosla, S., & Kaufman, D. S. (2010) · Bone · doi:10.1016/j.bone.2010.06.020 · Cited by 67
“Because fetal- and adult-derived MSCs appear to have some limitations, including disparate differentiation tendencies [17-21], we postulate that hESC-derived MSCs will provide improved opportunities for regenerative medicine.”
BackgroundCD271 as a Marker for Mesenchymal Stem Cells in Bone Marrow versus Umbilical Cord Blood
Watson, J. T., Foo, T., Wu, J., Moed, B. R., Thorpe, M., Schon, L. C., & Zhang, Z. (2013) · Cells Tissues Organs · doi:10.1159/000348794 · Cited by 66
“…and CB-CD271 cells, at passage 3, were plated in 6-well culture plates (5, 000 cells/well) and cultured in an osteogenic medium, which was based on DMEM and supplemented with 10% fetal bovine serum, 10 m M β-glycerophosphate, 100 n M dexamethasone and 50 μg/ml ascorbate [Rebelatto et al., 2008].”
MethodPleumeekers, M. M., Nimeskern, L., Koevoet, W. L., Kops, N., Poublon, R. M. L., Stok, K. S., & van Osch, G. (2014) · European Cells and Materials · doi:10.22203/ecm.v027a19 · Cited by 66
Sun, K., Zhou, Z., Ju, X., Zhou, Y., Lan, J., Chen, D., Chen, H., Liu, M., & Pang, L. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0390-4 · Cited by 66
“The eligibility criteria for including articles in this systematic review and meta-analysis were as follows: (1) all studies included were controlled comparison studies involving stem/progenitor cells and coimplantation in animals in vivo or coculturing of cells isolated from animals in vitro; (2) all studies included…”
BackgroundMethodWu, J., Sun, Y. W., Block, T. J., Marinkovic, M., Zhang, Z.-L., Chen, R., Yin, Y., Song, J., Dean, D. D., Lu, Z., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0437-6 · Cited by 65
Zhang, Y., Li, Y., Li, W., Cai, J., Yue, M., Jiang, L., Xu, R., Zhang, L., Li, J., & Zhu, C. (2018) · Stem Cells International · doi:10.1155/2018/7159465 · Cited by 65
“MSCs were originally found in bone marrow and can also be isolated from the umbilical cord, adipose tissue, dental pulp, and amniotic fluid [4, 5].”
BackgroundIntraoperative Stem Cell Therapy
Coelho, M. B., Cabral, J. M. S., & Karp, J. M. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150041 · Cited by 64
“These results are supported by other published studies that focus on the assessment of different adult stem cell sources (77, 79).”
ResultMarappagounder, D., Somasundaram, I., Dorairaj, S., & Sankaran, R. (2012) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-012-0040-5 · Cited by 63
“However, bone marrow-derived stem cells have a lower proliferative potency and have not proven promising candidates for the treatment of widespread diseases [13-18].”
BackgroundGenetic evaluation of mesenchymal stem cells by G-banded karyotyping in a Cell Technology Center
Borgonovo, T., Vaz, I. M., Senegaglia, A. C., Rebelatto, C. L. K., & Brofman, P. R. S. (2014) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2014.03.006 · Cited by 62
“1 46,XX [20] – P0,P1, P2 19 4n [1] 2 46,XY [35] – P0,P1, P2 51 – 3 46,XY [20] – P1, P2,P3 22 – 4 46,XY [12] – P0,P1, P2,P3 64 4n [1], chtg [3] 5 46,XY,inv(9)(p12q13) [15] – P0,P1, P2,P3 15 4n [2] 6 46,XY [20] – P2 20 4n [1] 7 46,XY [20] – P2 57 – 8 46,XY [20] – P2 32 – 9 46,XY [10] – P2,P3 11 – 10 46,XX [8] – P0,P1, P…”
Self-citationComparison of endometrial regenerative cells and bone marrow stromal cells
Wang, H., Jin, P., Sabatino, M., Ren, J., Civini, S., Bogin, V., Ichim, T. E., & Stroncek, D. F. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-207 · Cited by 62
“These studies have found that stromal cells produced from these various cell and tissue types have a similar phenotype [28-32].”
BackgroundResultResponse of stem cells from different origins to biphasic calcium phosphate bioceramics
Lobo, S. E., Glickman, R. S., da Silva, W. N., Arinzeh, T. L., & Kerkis, I. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2116-9 · Cited by 61
“Variations in the yield of cells, colony frequency, multipotency, proliferation rate, immunomodulatory properties, cytokine secretion, morphology, immunophenotype, transcriptome and proteome are some of the differences that have been previously reported (Shi et al. 2001; Kern et al. 2006; Bochev et al. 2008; Peng et a…”
BackgroundResult
Metadata
- Authors
- Rebelatto, C. K., Aguiar, A. M., Moretão, M. P., Senegaglia, A. C., Hansen, P., Barchiki, F., Oliveira, J., Martins, J., Kuligovski, C., Mansur, F., Christofis, A., Amaral, V. F., Brofman, P. S., Goldenberg, S., Nakao, L. S., & Correa, A.
- Affiliations
- Pontifícia Universidade Católica do Paraná (BR)
- Laboratorio Experimental de Cultivo Celular, Pontifícia Universidade Católica do Paraná, Rua Imaculada Conceição 1155, Curitiba 80215-901, Brazil; FIOCRUZ, Avenida Brasil 4365, Rio de Janeiro 21040-900, Brazil; Instituto de Biologia Molecular do Paraná, Rua Algacyr Munhoz Mader 3775, Curitiba 81350-010, Brazil; Núcleo de Investigação Molecular Avançada, Pontifícia Universidade Católica do Paraná, Rua Imaculada Conceição 1155, Curitiba 80215-901, Brazil
- ORCID
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 2008-07
- Volume
- 233
- Issue
- 7
- Pages
- 901-913
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2069780242
- Cited by
- 429
- References
- 83
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 16 · 2020: 25 · 2019: 25 · 2018: 16 · 2017: 23 · 2016: 24 · 2015: 32 · 2014: 41 · 2013: 38 · 2012: 44
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, adipose-derived stem cells, osteogenic differentiation, chondrogenic differentiation, adipogenesis, lipid droplets, alkaline phosphatase, type II collagen, immunophenotype, tissue repair
- MeSH terms
- Adipose Tissue, Adult, Aged, Alkaline Phosphatase, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Female, Fetal Blood, Humans, Middle Aged, Osteoblasts, Pregnancy, Adipocytes, Chondrocytes, Collagen Type II, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.